Expression of AT1 and AT2, as well as other RAAS components in cells from human astrocytomas, was variable, possibly related to clonal heterogeneity (Juillerat-Jeanneret et al, 2004). The gene discussed is AGTR1; the disease is astrocytoma (excluding glioblastoma).